-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
according to theAccording to the International Diabetes Federation, the number of people with diabetes in China reached 114.4 million (20-79 years old) in 2017, the highest number in the worldIt is forecast that themarket for anti-diabeticdrugs(http:// will grow from RMB51.2 billion in 2017 to RMB173.9 billion in 2028, with a CAGR of 11.8%recently, Chongqing Conkel LimitedCompany(http://announced that its company received the approval of the State Drug Administration to issue the "
Drug(http:// on the Gremmel tablets (commodity name "LiYien")supplementary application approval (lot number: 2019B02914), the drug specification 1mg successfully passed the
of imitation pharmaceutical(http://) quality and efficacy consistency evaluation Gremeta tablets, for type 2 diabetes, which controls diet, exercise therapy, and weight loss, does not adequately control blood sugar Gremeta tablets are not suitable for type 1 diabetes (e.g., treatment for diabetics with a history of ketoacidosis), diabetic ketoacidosis, or prediabetes induced coma or coma treatment Conker this variety successfully passed the consistency evaluation, is expected to obtain policy dividends, further improve their own variety competitive strength, and according to the drug intelligence data, so far through the Gremyaine tablet consistency evaluation of the enterprise (http:// 3 involving 2 specifications